Congress Asset Management CO Neurocrine Biosciences Inc Transaction History

Congress Asset Management CO

  • $14.4 Billion
  • Q3 2025

A detailed history of Congress Asset Management CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Congress Asset Management CO holds 2,690 shares of NBIX stock, worth $389,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,690
Holding current value
$389,673
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025
BUY
$123.98 - $146.67 $333,506 - $394,542
2,690 New
2,690 $377,000
Q1 2025

Apr 11, 2025
BUY
$107.22 - $153.29 $253,360 - $362,224
2,363 New
2,363 $261,000
Q2 2024

Aug 02, 2024
BUY
$130.86 - $143.19 $373,605 - $408,807
2,855 New
2,855 $393,000
Q3 2023

Nov 01, 2023
SELL
$94.02 - $117.1 $145,072 - $180,685
-1,543 Reduced 26.73%
4,229 $475,000
Q2 2023

Jul 27, 2023
SELL
$89.53 - $104.87 $81.9 Million - $95.9 Million
-914,281 Reduced 99.37%
5,772 $544,000
Q1 2023

Apr 21, 2023
BUY
$94.11 - $123.02 $209,677 - $274,088
2,228 Added 0.24%
920,053 $93.1 Million
Q4 2022

Jan 18, 2023
SELL
$106.72 - $127.06 $18.8 Million - $22.4 Million
-176,352 Reduced 16.12%
917,825 $0
Q3 2022

Nov 08, 2022
BUY
$92.03 - $107.81 $1.87 Million - $2.19 Million
20,335 Added 1.89%
1,094,177 $116 Million
Q2 2022

Aug 02, 2022
SELL
$75.79 - $100.07 $2.8 Million - $3.7 Million
-37,006 Reduced 3.33%
1,073,842 $105 Million
Q1 2022

Apr 20, 2022
BUY
$72.45 - $94.81 $14.6 Million - $19.1 Million
201,760 Added 22.19%
1,110,848 $104 Million
Q4 2021

Jan 28, 2022
SELL
$79.65 - $106.22 $8.18 Million - $10.9 Million
-102,684 Reduced 10.15%
909,088 $77.4 Million
Q3 2021

Nov 08, 2021
BUY
$86.18 - $99.03 $5.45 Million - $6.26 Million
63,207 Added 6.66%
1,011,772 $97 Million
Q2 2021

Aug 05, 2021
BUY
$89.43 - $102.27 $4.18 Million - $4.78 Million
46,731 Added 5.18%
948,565 $92.3 Million
Q1 2021

May 05, 2021
BUY
$87.57 - $119.4 $12.3 Million - $16.8 Million
140,893 Added 18.52%
901,834 $87.7 Million
Q4 2020

Jan 26, 2021
SELL
$86.91 - $108.33 $583,079 - $726,785
-6,709 Reduced 0.87%
760,941 $72.9 Million
Q3 2020

Nov 03, 2020
BUY
$96.16 - $135.15 $73.8 Million - $104 Million
767,650 New
767,650 $73.8 Million

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email